|
gptkbp:instanceOf
|
gptkb:drug
adenosine receptor agonist
|
|
gptkbp:approvalYear
|
2008
|
|
gptkbp:ATCCode
|
C01EB22
|
|
gptkbp:brand
|
gptkb:Lexiscan
|
|
gptkbp:CASNumber
|
313348-27-5
|
|
gptkbp:contraindication
|
gptkb:second-_or_third-degree_AV_block
sinus node dysfunction
|
|
gptkbp:eliminationHalfLife
|
2-4 minutes
|
|
gptkbp:excretion
|
renal
|
|
gptkbp:hasInChIKey
|
QXKHYNVANLEOEG-UHFFFAOYSA-N
|
|
gptkbp:hasMolecularFormula
|
C15H18N8O5
|
|
gptkbp:hasSMILES
|
CC1=NC2=C(N1)N=C(NC2=O)NCC3=NC(=O)N(C(=O)N3)C
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
regadenoson
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:manufacturer
|
gptkb:Astellas_Pharma
|
|
gptkbp:mechanismOfAction
|
selective A2A adenosine receptor agonist
|
|
gptkbp:metabolism
|
not extensively metabolized
|
|
gptkbp:molecularWeight
|
390.36 g/mol
|
|
gptkbp:pregnancyCategory
|
C (US)
|
|
gptkbp:PubChem_CID
|
gptkb:DB06213
CHEMBL1201832
6918537
5293727
|
|
gptkbp:routeOfAdministration
|
intravenous
|
|
gptkbp:sideEffect
|
headache
chest pain
flushing
dyspnea
|
|
gptkbp:UNII
|
4X6E73CJ0Q
|
|
gptkbp:usedFor
|
myocardial perfusion imaging
|
|
gptkbp:bfsParent
|
gptkb:A2A_adenosine_receptor
gptkb:Adenosine_A2A_receptor
gptkb:Lexiscan
|
|
gptkbp:bfsLayer
|
7
|